Skip to main content
. 2022 Oct 20;23(20):12603. doi: 10.3390/ijms232012603

Table 1.

Nutritional deficiencies in neurodegenerative disorders.

Nutrient Report of Deficiency Ref No.
Coenzyme Q10
  • Deficiency in cerebral cortex CoQ10 status in PD patients

  • Reduced CoQ10 in plasma and platelets in PD patients

  • Depleted levels of CoQ10 in blood associated with development of AD

  • Reduced CoQ10 in plasma or postmortem brain tissue of MSA patients

[18,19]
[20,21]
[22]
[23,24,25]
Selenium
  • Se deficiency in brain tissue in PD patients

  • Depleted Se levels in blood or brain tissue in AD

  • Se blood levels inversely associated with ALS

[26]
[27,28]
[29,30]
B-vitamins/NADH
  • Reduced B1 levels in blood and CSF fluid in PD patients

  • B1 deficiency in blood and autopsied brain samples from AD patients

  • B1 levels depleted in blood and CSF in ALS

  • Reduced blood B2 levels associated with developing ALS

  • Reduced blood B2 in PD patients

  • Reduced blood B2 in AD patients

  • Reduced B3 (niacin) in PD

  • Niacin intake inversely related to development of AD

[31,32,33]
[34]
[35,36]
[37]
[38]
[39,40]
[41]
[42]
l-carnitine/acetyl-l-carnitine
  • Reduced blood levels in PD

  • Reduced CSF levels in AD

  • Reduced levels of carnitine acetyltransferase in postmortem brain tissue of AD patients

[43,44,45]
[46]
[47]
PVitamin D3
  • Depleted D3 blood levels and increased risk of PD

  • Depleted D3 blood levels and increased risk of AD

  • Depleted D3 blood levels and increased risk of ALS

  • D3 deficiency reported in MSA

[48]
[49,50]
[51]
[52,53]